KONINKLIJKE PHILIPS NV Business Summary

Koninklijke Philips NV is a global health technology leader that generates revenue through capital equipment sales, recurring service contracts, and software-as-a-service (SaaS) subscriptions. The business is organized into three core segments: Diagnosis & Treatment (precision imaging and image-guided therapy), Connected Care (patient monitoring and informatics), and Personal Health (consumer oral and personal care). As of 2026, the company has successfully pivoted toward a circular economy model, targeting 25% of revenue from circular solutions, and has integrated AI-driven clinical decision support across its informatics platforms to enhance recurring margins. Philips competes directly with GE HealthCare, Siemens Healthineers, Medtronic, and ResMed. While Siemens and GE lead in large-scale imaging hardware, Philips holds a competitive advantage in integrated clinical informatics and image-guided minimally invasive surgery, positioning itself as a specialist in hospital workflow efficiency. Originally founded in 1891 by Gerard and Frederik Philips, the firm is currently led by CEO Roy Jakobs, who was proposed for re-appointment in February 2026 following his leadership through the Respironics recall recovery and a €2.5 billion productivity program. The executive team includes CFO Charlotte Hanneman, formerly of Stryker, and Chief Innovation & Strategy Officer Shez Partovi, who joined from Amazon Web Services to lead the company’s cloud and AI initiatives. The Supervisory Board is chaired by Feike Sijbesma, the former CEO of DSM. Notable institutional backing includes a 15% anchor stake held by Exor N.V. (the Agnelli family holding company), alongside major holdings by BlackRock and Vanguard, supporting a strategic focus on mid-single-digit sales growth and margin expansion through 2028.